122 related articles for article (PubMed ID: 8782086)
1. Mutational analysis of the estrogen receptor ligand-binding domain: influence of ligand structure and stereochemistry on transactivation.
Kohno H; Bocchinfuso WP; Gandini O; Curtis SW; Korach KS
J Mol Endocrinol; 1996 Jun; 16(3):277-85. PubMed ID: 8782086
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor residues required for stereospecific ligand recognition and activation.
Bocchinfuso WP; Korach KS
Mol Endocrinol; 1997 May; 11(5):587-94. PubMed ID: 9139802
[TBL] [Abstract][Full Text] [Related]
3. Multiple estrogen binding sites in the uterus: stereochemistry of receptor and non-receptor binding of diethylstilbestrol and its metabolites.
Chae K; Johnston SH; Korach KS
J Steroid Biochem Mol Biol; 1991 Jan; 38(1):35-42. PubMed ID: 1997122
[TBL] [Abstract][Full Text] [Related]
4. Diethylstilbestrol metabolites and analogs. Stereochemical probes for the estrogen receptor binding site.
Korach KS; Chae K; Levy LA; Duax WL; Sarver PJ
J Biol Chem; 1989 Apr; 264(10):5642-7. PubMed ID: 2925625
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity.
Chae K; Gibson MK; Korach KS
Mol Pharmacol; 1991 Nov; 40(5):806-11. PubMed ID: 1944245
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor stereochemistry: receptor binding and hormonal responses.
Korach KS; Levy LA; Sarver PJ
J Steroid Biochem; 1987; 27(1-3):281-90. PubMed ID: 3695485
[TBL] [Abstract][Full Text] [Related]
7. Molecular determinants of the stereoselectivity of agonist activity of estrogen receptors (ER) alpha and beta.
Mueller SO; Hall JM; Swope DL; Pedersen LC; Korach KS
J Biol Chem; 2003 Apr; 278(14):12255-62. PubMed ID: 12547836
[TBL] [Abstract][Full Text] [Related]
8. Diethylstilbestrol metabolites and analogs: differential ligand effects on estrogen receptor interactions with nuclear matrix sites.
Metzger DA; Curtis S; Korach KS
Endocrinology; 1991 Apr; 128(4):1785-91. PubMed ID: 2004602
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor stereochemistry: ligand binding and hormonal responsiveness.
Korach KS; Chae K; Gibson M; Curtis S
Steroids; 1991 May; 56(5):263-70. PubMed ID: 1877066
[TBL] [Abstract][Full Text] [Related]
10. Two transcription activation functions in the amino terminus of the mouse estrogen receptor that are affected by the carboxy terminus.
Gandini O; Kohno H; Curtis S; Korach KS
Steroids; 1997 Jul; 62(7):508-15. PubMed ID: 9253789
[TBL] [Abstract][Full Text] [Related]
11. Promoter and species specific differential estrogen-mediated gene transcription in the uterus and cultured cells using structurally altered agonists.
Curtis SW; Shi H; Teng C; Korach KS
J Mol Endocrinol; 1997 Jun; 18(3):203-11. PubMed ID: 9195474
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal mutagenesis between human alpha(L349, M528) and rainbow trout (M317, I496) estrogen receptor residues demonstrates their importance in ligand binding and gene expression at different temperatures.
Matthews JB; Clemons JH; Zacharewski TR
Mol Cell Endocrinol; 2001 Oct; 183(1-2):127-39. PubMed ID: 11604233
[TBL] [Abstract][Full Text] [Related]
13. Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination.
Pakdel F; Katzenellenbogen BS
J Biol Chem; 1992 Feb; 267(5):3429-37. PubMed ID: 1737796
[TBL] [Abstract][Full Text] [Related]
14. The analysis of chimeric human/rainbow trout estrogen receptors reveals amino acid residues outside of P- and D-boxes important for the transactivation function.
Petit FG; Valotaire Y; Pakdel F
Nucleic Acids Res; 2000 Jul; 28(14):2634-42. PubMed ID: 10908317
[TBL] [Abstract][Full Text] [Related]
15. Generation of estrogen receptor mutants with altered ligand specificity for use in establishing a regulatable gene expression system.
Whelan J; Miller N
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):3-12. PubMed ID: 8809181
[TBL] [Abstract][Full Text] [Related]
16. Function of N-terminal transactivation domain of the estrogen receptor requires a potential alpha-helical structure and is negatively regulated by the A domain.
Métivier R; Petit FG; Valotaire Y; Pakdel F
Mol Endocrinol; 2000 Nov; 14(11):1849-71. PubMed ID: 11075817
[TBL] [Abstract][Full Text] [Related]
17. Probing the structure and function of the estrogen receptor ligand binding domain by analysis of mutants with altered transactivation characteristics.
Eng FC; Lee HS; Ferrara J; Willson TM; White JH
Mol Cell Biol; 1997 Aug; 17(8):4644-53. PubMed ID: 9234721
[TBL] [Abstract][Full Text] [Related]
18. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast.
Wrenn CK; Katzenellenbogen BS
J Biol Chem; 1993 Nov; 268(32):24089-98. PubMed ID: 8226955
[TBL] [Abstract][Full Text] [Related]
19. Temperature dependence of estrogen binding: importance of a subzone in the ligand binding domain of a novel piscine estrogen receptor.
Tan NS; Frecer V; Lam TJ; Ding JL
Biochim Biophys Acta; 1999 Nov; 1452(2):103-20. PubMed ID: 10559464
[TBL] [Abstract][Full Text] [Related]
20. Directed evolution of human estrogen receptor variants with significantly enhanced androgen specificity and affinity.
Chen Z; Katzenellenbogen BS; Katzenellenbogen JA; Zhao H
J Biol Chem; 2004 Aug; 279(32):33855-64. PubMed ID: 15159406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
